What is Anoro Ellipta? An Overview of Medications and Pharmacology
•
4 min read
According to the FDA, Anoro Ellipta was first approved in 2013 for the long-term, once-daily maintenance treatment of airflow obstruction in adults with Chronic Obstructive Pulmonary Disease (COPD). What is Anoro Ellipta and how does its pharmacology help patients with chronic bronchitis and emphysema achieve better breathing?